(Q34208904)

31 July 2017

title

Effect of tumour necrosis factor and lipid A on functional and structural vascular volume in solid murine tumours (English)

1 reference

31 July 2017

0 references

van de Weil PA

1

1 reference

31 July 2017

Bouma GJ

2

1 reference

31 July 2017

van der Pijl A

3

1 reference

31 July 2017

Weitenberg ES

4

1 reference

31 July 2017

Lam AW

5

1 reference

31 July 2017

Bloksma N

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 November 1990

1 reference

British Journal of Cancer

31 July 2017

published in

1 reference

31 July 2017

volume

62

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

718-723

1 reference

Location of T cell and major histocompatibility complex antigens in the human thymus

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971527

Influence of adrenoceptor blockade on endotoxin-induced histopathological changes in murine Meth A sarcoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971527

The effects of melphalan and misonidazole on the vasculature of a murine sarcoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971527

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971527

Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971527

The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971527

Determinants of tumor blood flow: a review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971527

Effects of tumor necrosis factor (TNF) on transplanted tumors induced by methylcholanthrene in mice. A histopathologic study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971527

The relationship between regional variations in blood flow and histology in a transplanted rat fibrosarcoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971527

An endotoxin-induced serum factor that causes necrosis of tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971527

Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo

5 July 2018

1 reference

12 December 2020

Combination immunotherapy of cancer in a mouse model: synergism between tumor necrosis factor and other defense systems

1 reference

12 December 2020

Lymphoid tissue- and inflammation-specific endothelial cell differentiation defined by monoclonal antibodies

1 reference

12 December 2020

Macroscopic and microscopic early effects of tumour necrosis factor on murine Meth A sarcoma, and relation to curative activity

1 reference

12 December 2020

Viscous resistance to blood flow in solid tumors: effect of hematocrit on intratumor blood viscosity

1 reference

12 December 2020

Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo

1 reference

12 December 2020

Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy

1 reference

12 December 2020

Protease treatment combined with immunohistochemistry reveals heterogeneity of normal and neoplastic basement membranes

1 reference

12 December 2020

Effector mechanisms of cytolytically activated macrophages. II. Secretion of a cytolytic factor by activated macrophages and its relationship to secreted neutral proteases

1 reference

12 December 2020

Effect of adrenoceptor blockade on hemorrhagic necrosis of meth A sarcomata induced by endotoxin or tumor necrosis serum

1 reference

12 December 2020

Vascular occlusion and tumour cell death

1 reference

12 December 2020

Role of vasoactive amines in the antitumor activity of endotoxin

1 reference

12 December 2020

Muramyl dipeptide is a powerful potentiator of the antitumor action of various tumor-necrotizing agents

1 reference

12 December 2020

Vascular Endothelium as the Vulnerable Element in Tumours

1 reference

12 December 2020

Recombinant human tumor necrosis factor--I. Cytotoxic activity in vitro

1 reference

12 December 2020

Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines

1 reference

12 December 2020

Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor

1 reference

12 December 2020

Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.366

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference